Related by context. All words. (Click for frequent words.) 58 cells CTCs 54 CTCs 50 Circulating Tumor Cell 49 coronary artery blockages 49 KRAS mutation 48 Circulating Tumor Cells 48 NGAL 48 eTag assays 47 Flow cytometry 47 Septin9 biomarker 47 CellSearch System 47 Exome 47 prognostic markers 47 ptau 47 HER2 gene 47 atypical hyperplasia 47 skin sterol 47 RKIP 47 Her2/neu 47 micrometastasis 46 CD# + [002] 46 Metabolomic 46 microRNA biomarkers 46 Circulating tumor cells 46 Tr DNA 46 Squamous 46 Corus CAD 46 methylation markers 46 EpCAM expression 46 endothelial progenitor cells 46 sputum cytology 46 HuCNS SC ® 46 biomarkers 46 prostate carcinoma 46 breast carcinomas 46 peripheral blood mononuclear 46 lymph node 46 renal carcinoma 46 leukocytosis 45 telomerase inhibition 45 cell lysate 45 Efficacy endpoints included 45 MTWA 45 COLD PCR 45 ChIP 45 circulating EPCs 45 VSELs 45 leukocyte 45 NPM1 mutation 45 breast cancer susceptibility genes 45 tumor cells 45 circulating endothelial cells 45 serum PSA 45 squamous subtype 45 Oncotype 45 cytometry 45 mononuclear cells 45 FCGR3A 45 p# biomarker 45 molecular subtypes 45 serum biomarkers 45 adult neural stem 45 renal cell carcinomas 45 HER2 expression 45 abnormal cervical 45 reticulocytes 45 sentinel lymph node 45 carcinoid 45 EGF receptors 45 axillary lymph nodes 45 proton MR spectroscopy 45 HERmark 45 NMP# 45 gene expression profiles 44 bladder tumors 44 delta isoform 44 metastatic lesions 44 Cervista HPV HR 44 genomic markers 44 BRAF V#E mutation 44 immunohistochemical 44 specific antigen PSA 44 micrometastases 44 PLAC test 44 adipose derived regenerative 44 NSCLC tumors 44 liver metastasis 44 SureSelect 44 urine cytology 44 ChIP chip 44 NPM1 44 eosinophil 44 HCV RNA 44 hemoglobin hematocrit 44 distant metastases 44 tubulin inhibitor 44 Cutaneous T 44 premalignant lesions 44 Veridex 44 inflammatory biomarkers 44 pancreatic adenocarcinoma 44 colorectal carcinoma 44 locoregional 44 sustained virologic response 44 IgG antibodies 44 seminoma 44 endometrial 44 lung adenocarcinoma 44 gene expression patterns 44 VeraTag 44 biopsied tissue 44 metastatic tumors 44 neutrophil count 44 ASCUS 44 nonsmall cell lung cancer 44 HER2 positive cancers 44 PD2i ® 44 cystatin C 44 Lp PLA2 44 PlGF 44 troponin T 44 colorectal tumor 43 baseline LDH 43 AlloMap molecular expression 43 xCELLigence System 43 immunochemical 43 MYDICAR 43 FISH fluorescence 43 Tumor Microenvironment 43 AtherOx 43 miRNA biomarkers 43 mesothelin 43 cardiac troponin 43 pancreatic islet cell 43 monocyte chemoattractant protein 43 Hematopoietic stem cells 43 somatic mutations 43 miRNA expression patterns 43 MAPCs 43 ProteinChip 43 Azedra 43 granulocyte 43 metastatic lymph nodes 43 incidentalomas 43 Trofex 43 Prostate Specific Antigen PSA 43 tumor hypoxia 43 Septin 9 43 interstitial fluid 43 GlucoLight 43 lung adenocarcinomas 43 sentinel lymph nodes 43 KRAS mutations 43 ImmuKnow assay 43 pulmonary metastases 43 SUVmax 43 florbetaben 43 pancreatic cancers 43 Multi Lineage Progenitor 43 flow cytometry 43 biomarker 43 recombinant factor VIIa 43 sarcomatoid 43 HLA antigens 43 microfluidic devices 43 PSADT 43 endometrial cancers 43 histological subtype 43 serum creatinine 43 CD4 + T 43 ESBA# 43 ELISpot 43 malignant lesions 43 Sanger sequencing 43 CD# expression [001] 43 nucleated cells 43 EBUS FNA 43 precancers 43 Vidaza ® 43 miRview squamous 43 splice junctions 43 DNA Sequencing 43 flow cytometer 43 median CD4 43 BCR ABL mutations 43 prostate cancer PCa 43 lactate dehydrogenase LDH 43 IgM antibody 43 aggregated Abeta 43 tumor biopsies 43 endoglin 43 gene expression microarrays 43 protein biomarkers 43 AlloMap 43 MUC1 protein 43 medullary thyroid cancer 43 formalin fixed paraffin embedded 43 olaparib 43 carcinoid tumor 43 epithelial tumors 43 lobular carcinoma 43 Shiekhattar 43 Hepatocellular Carcinoma HCC 43 MammaPrint ® 43 stratify patients 43 FDG-PET/CT 43 molecular biomarker 43 DNA microarrays 43 mouse neural stem 43 SELDI TOF MS 43 Aethlon Hemopurifier R 43 atypia 43 EGFR mutation 43 central corneal thickness 43 ImmuKnow 43 MetaChip 43 PROCHYMAL 43 quantitative gene expression 43 CD# + [001] 43 CD4 + cell 43 intravascular hemolysis 43 myeloperoxidase 43 P selectin 43 prostate specific 43 Situ Hybridization 43 monoclonal 43 percutaneous biopsy 43 GAGs 42 PCA3 42 differentially expressed genes 42 uPA 42 pharmacogenomic tests 42 MGd 42 flow cytometers 42 sentinel nodes 42 B7 H3 42 PITX2 42 tumors 42 TGFBR1 * 6A 42 gooey amyloid 42 analyte 42 CYT# potent vascular disrupting 42 operable breast cancer 42 PSA kinetics 42 FFPE 42 CellSearch Circulating Tumor 42 Mammostrat 42 circulating lymphocytes 42 Newton Cheh 42 noninvasive imaging 42 genetic biomarkers 42 gastrointestinal stromal tumors 42 HemoShear 42 CD4 T 42 bisulfite sequencing 42 CINtec R 42 HER2 overexpression 42 lung pancreatic 42 allogeneic HSCT 42 companion diagnostics 42 prostate tissue 42 PSA velocity 42 biomolecular interactions 42 baseline CD4 + 42 AGTR1 42 carotid plaque 42 p# antigen 42 trastuzumab DM1 T DM1 42 antigen PSA 42 Thalomid ® 42 SiMoA 42 Targeted Therapy 42 microRNA expression 42 biochemical markers 42 Tlsty 42 Paroxysmal Nocturnal Hemoglobinuria PNH 42 miRview ™ squamous 42 stem cell engraftment 42 HIV RNA 42 lymphocyte count 42 cytoreductive surgery 42 angiographic outcomes 42 exome sequencing 42 BRAF mutation 42 Prostate Specific Antigen 42 viral nucleic acid 42 exome 42 malignancy 42 lymph nodes 42 TMPRSS2 ERG 42 transcriptomics 42 Getzenberg 42 Belldegrun 42 CD4 42 Antigen Specific 42 ACRIN 42 lung carcinomas 42 biomarker identification 42 breast cancer subtypes 42 Biophysical Corporation 42 Diffuse Large B 42 tissue biopsies 42 mesenchymal stem cell 42 Xcellerated T Cells 42 GeneSightRx 42 PITX2 methylation 42 vascular endothelial 42 MammaPrint R 42 miRNA molecules 42 fine needle aspiration 42 Solid Tumors 42 EGFR receptor 42 TMPRSS2 ERG fusion 42 familial ALS 42 CIN3 42 malignant prostate 42 transfection reagents 42 leucocyte 42 induced sputum 42 T#I [002] 42 PNH patients 42 breast carcinoma 42 sentinel node 42 Ontak 42 Patient Outcomes 42 Chronic Myelogenous Leukemia 42 LDL particle 42 assay detects 42 prostate tumor 42 GeneSearch BLN Assay 42 BSGI MBI 42 PROLARIS 42 MAGE A3 42 microRNA profiling 42 lymph node metastases 42 nomograms 42 platelet reactivity 42 DuraHeart 42 osteosarcomas 42 diagnostic biomarkers 42 microvascular disease 42 mm ³ 42 karyotyping 42 radiographic outcomes 42 hepatocellular carcinoma 42 patients undergoing CABG 42 metastases 42 glioblastoma 42 Response Genetics 42 Myoblast Program 42 cTnT 42 Atypical Hemolytic Uremic Syndrome 42 splice variants 42 SPINK1 42 specific antigen 42 result lipid engorged 42 Tie2 42 cerebrospinal fluid CSF 42 renal tumors 42 neoadjuvant 42 lung nodules 42 OnDose TM 42 cisplatin resistant 42 lymphovascular invasion 42 Luminex xMAP technology 42 thyroid nodules 42 Flow Cytometry 42 Histologically 42 HybSelect 42 metastatic cancer 42 DNA Methylation 42 microarray analysis 42 induced pluripotent 42 pharmacodynamic biomarkers 42 Vascugel 42 #F FDG 42 Fc gamma receptors 42 colorectal liver metastases 42 colorectal cancer CRC 42 virtual colonography 42 haematopoietic 42 Follicular Lymphoma 42 hematopoietic cells 42 castrate resistant prostate cancer 42 progenitor cell 42 immunostaining 42 MIBG 42 lymphocytosis 42 creatinine levels 41 Dr. Grekos 41 tumor 41 obatoclax 41 HER2 receptor 41 buffy coat 41 HER2 41 miRview ® 41 breast cancer gene mutation 41 glioblastomas 41 fibrocytes 41 metabolomics driven 41 oligodendrocyte progenitor cells 41 OncoVEX 41 Cytometry 41 undetectable HBV DNA 41 malignancies 41 CD3 + 41 STRIDE PD 41 Genpathway 41 engineered bladders 41 neuroendocrine carcinoma 41 hybridoma 41 humanised antibody 41 antigen PSA levels 41 Salim Yusef 41 qRT PCR 41 PCa 41 mammary cells 41 flow cytometric 41 Peripheral Blood 41 endothelial progenitor cell 41 prostate cancer CaP 41 biomarker discovery validation 41 Quanterix 41 breast tumors 41 fluorescence imaging 41 taxane resistant 41 hA# 41 Roche NimbleGen 41 NATRECOR ® 41 cytogenetic 41 poly ADP ribose polymerase 41 LHRH receptor positive 41 PD2i R 41 immunofluorescence 41 fetal fibronectin test 41 pediatric acute lymphoblastic 41 intraductal 41 cancerous lymph nodes 41 Vicinium TM 41 mucinous 41 urothelial carcinoma 41 leukemic cells 41 miRNA expression 41 ALCL 41 Neoadjuvant 41 endpoint assays 41 pCR 41 myeloma cells 41 Non Hodgkin Lymphoma 41 S#A# [002] 41 cTnT levels 41 locoregional recurrence 41 positron emission 41 BladderChek 41 Phase #/#a trial 41 morphologic 41 GenPath 41 metastatic disease 41 pro angiogenic 41 immunomagnetic 41 Microarrays 41 Renal Cell Carcinoma RCC 41 Solazed 41 histologic subtypes 41 collagenase 41 Antigens 41 PRESEPT study 41 unresectable tumors 41 sustained virological response 41 rtPA 41 prognostically 41 cTnI 41 micronuclei 41 Sequencing Systems 41 Preclinical Study 41 paclitaxel eluting stents 41 megakaryocytes 41 exosomes 41 Septin9 41 lung metastases 41 diagnostic modality 41 Ki# 41 islet beta 41 tumoral 41 multiplex PCR 41 sarcosine 41 XIENCE V demonstrated 41 BiTE antibodies T 41 CD4 + 41 causative gene 41 endometrioid 41 endothelial cell 41 precancerous spots 41 flavopiridol 41 atypical ductal hyperplasia 41 Monoclonal 41 please visit www.metabolon.com 41 baseline CD4 41 Proteomic 41 advanced adenomas 41 K ras mutations 41 SPY imaging 41 non nucleoside 41 Barrett Esophagus 41 ALTROPANE 41 Lp PLA 2 41 relapsed MM 41 antiviral therapies 41 lymphocyte 41 mammographically 41 Cardiotoxicity 41 tumor metastases 41 nucleoside naive 41 Dengue Hemorrhagic Virus 41 Haptoglobin 41 GIPET 41 druggable targets 41 HLA typing 41 HNPCC 41 ApoA1 41 Rainbow SET 41 Cellvizio 41 Mass spectrometry 41 CMV infection 41 Rosetta Genomics microRNA 41 anti JCV antibodies 41 Immunoassays 41 multiplex assay 41 MALDI-TOF/TOF 41 PEG SN# 41 ChIP Seq 41 sensitivity specificity 41 PCR Polymerase Chain Reaction 41 endometrial adenocarcinoma 41 prostatic fluid 41 HAAH 41 hyperplastic 41 apoB 41 transfection 41 granzyme B 41 proteomic 41 histologically 41 PD2i Analyzer 41 Malignant Melanoma 41 Annexin V 41 GIST tumors 41 melanoma tumors 41 Anti Bacterial Envelope 41 Intravesical 41 visit www.genenews.com 41 cervical lymph node 41 CyPath ® assay 41 natriuretic peptides 41 hepatitis C genotype 41 DAVANAT 41 Aspergillus infections 41 EUS FNA 41 5 hmC 41 underwent surgical resection 41 PERSEUS clinical program 41 uterine fibroid embolization 41 cells hESCs 41 pelvic lymph nodes 41 INFUSE ® 41 histopathologic examination 41 Bucindolol 41 GTC recombinant human 41 Antibiotic resistant infections 41 Bezielle 41 genomic loci 41 chromosome aberrations 41 antiproliferative effects 41 Carcinoma 41 CD# expressing 41 NAbs 41 hemodialysis patients 41 LightTouch 41 gastrointestinal stromal tumors GIST 41 BrachySil TM 41 LungExpress Dx TM 41 ovarian carcinoma 41 5 Fluorouracil 41 bone metastasis 41 HER2 ErbB2 41 Gene Expression Profiling 41 lymphocyte counts 41 causal variants 41 immunohistochemical analysis 41 CD4 cell 41 Chronix 41 NT proBNP 41 precancer 41 advanced epithelial ovarian 41 retinal nerve 41 definite stent thrombosis 41 NimbleGen arrays 41 LNA TM 41 node metastases 41 ependymomas 41 monogenic 41 hematopoetic stem cells 41 ovarian tumors 41 iCell Cardiomyocytes 41 allogeneic bone marrow 41 Cell TRC 41 pharmacodynamic effects 41 mammographic density 41 Third Eye Retroscope 40 Registry NOPR 40 CellPort Technologies 40 VeriStrat 40 adipose fat 40 Myocet 40 VKORC1 40 ductal carcinoma 40 ALN TTR 40 bDNA 40 epigenetic therapies 40 Stereotactic Body Radiation Therapy 40 cell hESC derived 40 cellTRAY 40 hematopoietic stem cells 40 biopsy 40 Affymetrix microarray technology 40 molecular biomarkers 40 bioluminescent imaging 40 kidney urologic 40 Situ Hybridization FISH 40 INTERCEPT red 40 R0 resection 40 metastatic prostate cancer 40 MitraClip device 40 Romidepsin 40 Biochips 40 E2F Decoy 40 chromosomal mutations 40 HIV tropism 40 R Bortezomib 40 interferon beta therapy 40 gefitinib Iressa 40 motesanib 40 Histopathologic 40 underwent resection 40 ganetespib 40 Dr. Pestell 40 MarginProbe 40 complete cytogenetic response 40 troponin 40 malignant pheochromocytoma 40 epithelial tissues 40 bone marrow biopsy 40 uveal melanoma 40 chromosomal abnormalities 40 eGFR 40 XIENCE V stent 40 carcinoma HCC 40 hsCRP 40 proteomic analysis 40 Cell Lung Cancer 40 white matter hyperintensities 40 severe neutropenia 40 gene fusions 40 xCELLigence 40 prostate cancers 40 Axiogenesis 40 biochemical recurrence 40 Xelox 40 ovarian malignancy 40 PROCRIT R 40 gastric carcinoma 40 P#X# 40 validating biomarkers 40 TMEM 40 SmartChip System 40 serum prostate 40 metastatic neuroendocrine tumors 40 prostatic adenocarcinoma 40 precursor lesions 40 nucleotide variations 40 resected tumors 40 Alessio Fasano 40 Phase III HEAT 40 VerifyNow 40 hemoglobin concentration 40 ovarian pancreatic 40 Mehmet Toner 40 neural progenitor 40 carotid artery thickness 40 NT proBNP assay 40 curable cancers 40 ELISA assays 40 BRCA mutation 40 infectious prion protein 40 antibody antigen 40 HbF 40 carcinoid tumors 40 gadolinium enhanced 40 IGF 1R 40 antiangiogenic therapy 40 PIK3CA 40 predictive biomarkers 40 AMD# [003] 40 EGFR expression 40 Cell Lymphoma 40 Viral load 40 adult mesenchymal stem 40 bioinformatic approaches 40 distant metastasis 40 CellSearch TM System 40 Breast Tumors 40 FFPE tissues 40 non squamous 40 gene loci 40 DNA Microarray 40 nuchal translucency 40 PSP# [002] 40 CD8 + lymphocytes 40 thymidylate synthase TS 40 assessing T DM1 40 polymorphonuclear 40 nestin 40 INTEGRILIN 40 ACTCellerate ™ 40 5q deletion 40 EGFR mutation status 40 ClariFI 40 miRNA genes 40 odanacatib 40 miRNA profiling 40 PSA nadir 40 Hyperlipidemia 40 chemosensitivity 40 acute PAO 40 Cancer Stem Cells 40 lobular breast cancer 40 hormone receptor status 40 bone scintigraphy 40 human leukocyte antigens 40 pegfilgrastim 40 microarray 40 precancerous condition 40 transcranial Doppler ultrasound 40 cytologic 40 OrbusNeich patented endothelial progenitor 40 INC# 40 CLL cells 40 PathFinderTG 40 mononuclear cell 40 NHGRI Large Scale 40 viral genomes 40 ocrelizumab 40 allogeneic stem cell 40 HCT# 40 MAbs 40 reproducibly 40 PCA3 assay 40 metastatic 40 WaveScan 40 protein biomarker 40 Metastatic 40 Masimo Rainbow SET Pulse 40 endometrial carcinoma 40 acinar cells 40 EOquin 40 prion 40 viral tropism 40 plasma renin activity 40 PCR assay 40 Molecular Diagnostic 40 BRCA mutations 40 SPIRIT IV 40 OvaRex R 40 Eg5 40 Biocept 40 PARP inhibitor 40 RT qPCR 40 bardoxolone 40 hemangioblast 40 physiological parameters 40 NMIBC 40 N telopeptide 40 Chronic Lymphocytic Leukemia CLL 40 FDG PET scans 40 oral taxane 40 pancreatic carcinoma 40 scintigraphic 40 laser capture microdissection 40 DNA microarray 40 extracolonic findings 40 tarenflurbil 40 ALDH br cells 40 metabolomic profiling 40 miRview meso 40 miRNAs 40 pre cancerous polyps 40 genotypic resistance 40 sestamibi 40 genomic profiling 40 iPSCs 40 AdnaGen 40 Allogeneic 40 PET tracers 40 PCA3 gene 40 #T# L1 40 putative biomarkers 40 Progenitor Cells 40 Tony Wyss Coray 40 Personalized Immunotherapy 40 Hemospan 40 TheraSphere 40 magnetic resonance spectroscopy MRS 40 proteomes 40 Robert Siliciano 40 congenital CMV infection 40 National Oncologic PET 40 Ischemic 40 hoFH patients 40 Cedars Sinai Maxine Dunitz 40 CA9 SCAN 40 confocal microscopy 40 myocardial necrosis 40 Ebola Hemorrhagic Virus Lassa 40 nanomolar 40 microsatellite instability 40 DNA methylation markers 40 VEGF expression 40 CSF Tf 40 enlarged spleens 40 miRNA 40 optical biosensors 40 Tem PCR 40 quantitative multiplexed gene 40 Prognostic Value 40 G CSF 40 Tumor shrinkage 40 FFR measurements 40 echocardiographic 40 immunochemical fecal occult 40 Contura MLB 40 endometrial hyperplasia 40 kinase profiling 40 enzyme immunoassay EIA 40 NMP# BladderChek Test 40 ependymoma 40 liver colon rectal 40 Localized Prostate Cancer 40 plasma kallikrein inhibitor 40 pericytes 40 nadir CD4 cell 40 Recurrence Score 40 sPLA2 40 Embryonic Stem 40 Hurthle cell 40 albuminuria 40 pharmacodynamic markers 40 pharmacogenetic test 40 Urnovitz 40 abnormal cytology 40 coronary calcium 40 patented Sertolin TM 40 HIF PHI 40 optical coherence tomography 40 overt nephropathy 40 Perlegen 40 tissue microarray 40 lymphocytes 40 AQUA ® 40 Myocardial Perfusion Imaging 40 TearLab TM 40 ACTCellerate 40 gadolinium enhancing lesions 40 leukapheresis 40 INACTINE 40 Biomerk Tumorgrafts 40 Transplant Recipients 40 stromal 40 KRAS oncogene 40 IGFBP 40 latent TB infection 40 RECIST Response Evaluation Criteria 40 germinal center 40 Vitro Diagnostic 40 BioMAP ® Systems 40 Enzyme Replacement Therapy 40 PROMUS Element Stent 40 Embozene TM Microspheres 40 IMPROVE HF 40 selective inhibitors 40 Rectal cancer 40 castrate resistant 40 INT# [002] 40 Smad7 40 d' Azzo 40 activated partial thromboplastin 40 metaglidasen 40 mSEPT9 40 GBM tumors 40 Antigen CEA 40 serous ovarian cancer 40 untreated metastatic melanoma 40 Epidermal Growth Factor Receptor 40 Regenerative Cell 40 APTIMA HPV 40 cobas 40 ALSYMPCA 40 CYP#C# [001] 40 cerebral oximetry 40 Immunohistochemistry IHC 40 undergo prostate biopsy 40 myocardial perfusion 40 RQ PCR 40 peritoneal carcinomatosis 40 anti apoptotic proteins 40 bFGF 40 deriving embryonic stem 40 secretory phospholipase A2 sPLA2 40 Masimo Rainbow SET 40 catheter angiography 40 GRNOPC1 contains 40 CIN2 + 40 BioSTAR ® 40 preserved ejection fraction 40 HDL Selective Delipidation 40 epoetin beta 40 metabolomic 40 HBsAg 40 EnVivo 40 Viatronix 40 radiochemotherapy 40 NMP# R 40 cubic millimeter 40 neutrophil gelatinase associated lipocalin 40 Timothy Rebbeck 40 cancerous tissue 40 ResponseDX Lung TM 40 fluorophores 40 invasive carcinoma 40 premalignant 40 alkaline phosphatase ALP 40 MORAb 40 retinal vein occlusion 40 biopsies 40 serum phosphate 40 quantitative PCR 40 Domchek 40 SERMs 40 cytologically 40 MAGE A3 ASCI 40 NADiA ProsVue 40 HER2 positive tumors 40 redox active 40 glioblastoma tumors 40 sentinel lymph node biopsy 40 FORE SIGHT 40 liver transplant recipients 40 colony stimulating factors 40 pain palliation 40 ChemoFx 40 Progenitor Cell 40 UOHI 40 trophoblasts 40 WT1 40 recombinant tissue plasminogen 40 cintredekin besudotox 40 ADVEXIN efficacy 40 urothelial cancer 40 SYMMETRY trial 40 mutated BRAF gene 40 silicon photomultipliers 40 cytological 40 diagnostic assays 40 adipose stem cells 40 medulloblastomas 40 prostate biopsy 40 reverse vaccinology 40 proteinuria 40 histologies 40 vernakalant hydrochloride 40 perfusion defects 40 polyp detection 40 Onconase 40 XIENCE PRIME 40 malignant growths 40 myeloproliferative neoplasms 40 Delcath PHP System 40 epithelial cell 40 chronic HCV 40 multiphoton microscopy 40 anti angiogenic therapy 40 endometrial tumors 40 SELDI TOF 40 PLX cells 40 MassARRAY 40 geneX ® 40 Vidofludimus 40 frequently benign tumor 40 #.#ng/ml 40 www.clarientinc.com 40 bone metastases